1. Home
  2. EXEL vs MOH Comparison

EXEL vs MOH Comparison

Compare EXEL & MOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exelixis Inc.

EXEL

Exelixis Inc.

HOLD

Current Price

$43.87

Market Cap

11.1B

Sector

Health Care

ML Signal

HOLD

Logo Molina Healthcare Inc

MOH

Molina Healthcare Inc

HOLD

Current Price

$133.95

Market Cap

8.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXEL
MOH
Founded
1994
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.1B
8.9B
IPO Year
2000
2003

Fundamental Metrics

Financial Performance
Metric
EXEL
MOH
Price
$43.87
$133.95
Analyst Decision
Buy
Hold
Analyst Count
21
13
Target Price
$46.60
$185.00
AVG Volume (30 Days)
2.7M
2.2M
Earning Date
02-10-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
57.95
N/A
EPS
2.78
8.92
Revenue
$2,320,126,000.00
$43,563,000,000.00
Revenue This Year
$14.86
$7.91
Revenue Next Year
$14.93
$8.13
P/E Ratio
$15.36
$14.21
Revenue Growth
6.98
11.23
52 Week Low
$32.38
$121.06
52 Week High
$49.62
$359.97

Technical Indicators

Market Signals
Indicator
EXEL
MOH
Relative Strength Index (RSI) 51.45 29.59
Support Level $40.92 $121.06
Resistance Level $44.28 $185.40
Average True Range (ATR) 1.48 7.41
MACD 0.03 -6.88
Stochastic Oscillator 70.53 15.17

Price Performance

Historical Comparison
EXEL
MOH

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About MOH Molina Healthcare Inc

Molina provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in just four states—California, New York, Texas, and Washington—account for over half of its enrollees.

Share on Social Networks: